10x Genomics, Inc. (0A88)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 71.64 |
|---|---|
| 52-week range | 15.27 – 102.81 |
| Return, 1 month / 3 months | −4.9% / +51.6% |
| Return, 1 year / 3 years | – / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 74.2% |
| Worst drawdown (1 year) | -29.0% |
| Average daily value traded | 0.37M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
10x Genomics makes laboratory instruments, consumables and software for studying biology at the level of individual cells and their spatial organisation. Its platforms, including Chromium, Visium and Xenium, are used by academic and pharmaceutical research laboratories to analyse genetic material and tissue samples. The company is based in Pleasanton, California, and supplies customers engaged in life science research and drug discovery.
10x Genomics, Inc. trades under the code 0A88 on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
10x Genomics, Inc. (0A88) trades on the London Exchange in UK. It last closed at USD 71.64 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 917 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 83.0% | ||
| From 52-week high | -25.8% | ||
| Momentum | 98 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 51.6% | ||
| 6-month return | 243.1% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 74.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.0% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.37M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | −4.9% |
| 3 months | +51.6% |
| 6 months | +243.1% |
| 1 year | – |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 72.18 / 39.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.79 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.